Patterns of treatment (trx) and safety of angiogenesis inhibitors in patients (pts) with advanced renal cell carcinoma (RCC) in France.
M. Gross-Goupil
Honoraria - Analysis Group
S. Oudard
Consultant or Advisory Role - Bayer; Novartis; Pfizer
Honoraria - Analysis Group; Bayer; Novartis; Pfizer
A. Levy
Honoraria - Analysis Group
R. Elaidi
No relevant relationships to disclose
F. Scotte
Honoraria - Roche
M. S. Duh
Research Funding - GlaxoSmithKline
S. P. Sarda
Research Funding - GlaxoSmithKline
C. Korves
Research Funding - GlaxoSmithKline
R. Goglia
Research Funding - GlaxoSmithKline
P. Ramamurthy
Research Funding - GlaxoSmithKline
M. Neary
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
B. Escudier
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - Analysis Group; AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche